ALMRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Alamar Biosciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$26.30+1.02 (+4.03%)
Close on Oct 19, 2026
- Market cap
- $1.54B
- P/E (TTM)
- –
- Dividend yield
- –
Alamar Biosciences, Inc. revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q2 25 | Q1 25 | % of revenue | YoY |
|---|---|---|---|---|---|---|
| Product Revenue | $23.27M | $21.34M | $12.04M | $9.17M | 79.1% | +93.3% |
| Consumables | $15.48M | $13.96M | $6.27M | $5.02M | 52.6% | +147.0% |
| Instruments | $7.79M | $7.38M | $5.77M | $4.15M | 26.5% | +34.9% |
| Service and Other Revenue | $6.16M | $4.69M | $4.12M | $3.92M | 20.9% | +49.4% |
| Services | $6.16M | $4.69M | $4.12M | $3.67M | 20.9% | +49.4% |
| Other revenue | – | – | $0 | $250.00K | – | – |
By region
| Revenue | Q2 26 | Q1 26 | Q2 25 | Q1 25 | % of revenue | YoY |
|---|---|---|---|---|---|---|
| United States | $19.66M | $14.91M | $9.52M | $9.47M | 66.8% | +106.4% |
| Europe, Middle East and Africa | $6.58M | $3.97M | $3.95M | $1.42M | 22.4% | +66.6% |
| Asia Pacific | $2.69M | $2.41M | $2.32M | $450.00K | 9.1% | +15.5% |
| Americas (excluding United States) | $503.00K | $1.29M | $364.00K | $20.00K | 1.7% | +38.2% |
| United Kingdom | – | $3.46M | – | $1.73M | – | – |
From the segment and revenue-disaggregation notes of Alamar Biosciences's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.